Gilead Sciences, Inc. announced new and updated positive results from three cohorts of the Phase 2 TROPHY-U-01 study of Trodelvy for the treatment of...
Bristol Myers Squibb announced three-year follow-up results from the Phase 3 CheckMate -274 trial, demonstrating significant sustained clinical benefits with Opdivo (nivolumab) for the adjuvant...
Michelson Philanthropies and AAAS/Science award Dr. Aleksandar Obradovic,of the Department of Systems Biology at Columbia University Irving Medical Center, with the 2023 Michelson Philanthropies & Science Prize for Immunology....
In collaboration with InPlay and Bosch Sensortec, SparkFun is pleased to release two new IoT development boards: the SparkFun NanoBeacon Board - IN100 and...
Ligand Pharmaceuticals Incorporated announced that its partner Travere Therapeutics, Inc. has received accelerated approval from the U.S. Food and Drug Administration for FILSPARI to...
